STUDDS Accessories Q2 Results
Net Profit Rs. 20.62 cr. up 18% YoY and 2% QoQ.
Revenue Rs. 154 cr. up 6% YoY and 3% QoQ.
EBITDA Rs. 29.84 cr. up 12% YoY but down 1% QoQ.
EBITDA margin at 19.32%, higher YoY but lower QoQ.
STUDDS: Fresh Investment in US Subsidiary Bikerz Inc.
Board approves USD 99,897 investment in its wholly owned US subsidiary.
Bikerz manages import and distribution of SMK helmets in the US.
STUDDS: To Incorporate Wholly Owned Subsidiary in Spain
Company to set up a new subsidiary in Spain with capital up to EUR 1 million to strengthen European distribution.
Brigade Enterprises: Signs 90-Year Lease in Technopark, Trivandrum
Lease secured for 4.859 acres to develop 1.2 mn sq. ft. of Grade-A office + 200+ key 5-star hotel.
GMR Airports: Sponsor Support for Rs. 750 cr. Loan
GMR Cargo & Logistics secures Rs. 750 cr. term loan from Axis Bank for Delhi Cargo City; parent pledges and provides NDU on 51% shares.
Leela Hotels: Global Expansion with Dubai Sofitel The Palm
Leela acquires stake in the 23-acre beachfront property in Dubai, rebranding it as “The Leela”—its first global flagship.
Mini Diamonds: Wins USD 2 Million Export Order
Company bags USD 2 mn (Rs. 17.8 cr.) lab-grown diamonds export order from Singapore; to be completed within two months.
SW Solar: Sterling & Wilson Wins Rs. 1,313 cr. EPC Project in South Africa
Secures 240 MW AC turnkey solar project; FY26 EPC inflows cross Rs. 5,088 cr.
SAMHI Hotels: Occupancy Rising Post-Diwali
Management sees strong demand with mid-70s occupancy; GST 2.0 changes impacted business.
FirstCry: Inter-Se Agreement Terminated
Following conditions being met, shareholders are no longer restricted from transferring or voting certain shares.
Biocon: Bengaluru Facility Gets FDA VAI Classification
US FDA categorizes the facility as VAI after inspection—no major compliance issues.
CarTrade: Consolidation Talks with CarDekho Called Off
Both firms mutually decide to halt consolidation; CarTrade to continue focusing on core platforms.
Medicamen Biotech: Expansion in Regulated & Complex Therapies
Company expanding into oncology and regulated markets, strengthening long-term growth drivers.
Leave A Comment